UPDATE: JPMorgan Upgrades PTC Therapeutics (PTCT) to Overweight

October 7, 2020 4:07 AM EDT Send to a Friend
(Updated - October 7, 2020 6:05 AM EDT)

(updating comment)JPMorgan analyst Eric Joseph upgraded PTC Therapeutics (NASDAQ: PTCT) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login